Science
Mechanism of Action
This ingredient exerts its effects primarily through 1,8-cineole (eucalyptol), which functions as an anti-inflammatory agent by modulating the body's response to infection, reducing redness and soothing sensations of heat through the inhibition of inflammatory mediators such as tumor necrosis factor (TNF), interleukin-1, leukotrienes, and thromboxane. It also possesses antibacterial and antimicrobial properties, with 1,8-cineole disrupting bacterial cell walls to increase permeability, leading to the release of essential bacterial proteins and nucleic acids. Furthermore, it aids in rebalancing oily skin by regulating sebum production and potentially reducing the size of sebaceous glands. Its phenolic compounds also contribute to antioxidant activity and may offer depigmenting effects by inhibiting tyrosinase and melanin production.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 Eucalyptus loxophleba essential oil demonstrated significant inhibitory effects on bacterial strains at concentrations between 14 to over 50 mg/ml.
- 02 Eucalyptus oils, in general, exhibited variable antimicrobial activity against a range of medically important pathogens, with concentrations from 0.25% to 8.0% (v/v) effectively inhibiting or killing most microorganisms.
- 03 Eucalyptus globulus essential oil (a related species) showed notable antibacterial activity against Staphylococcus aureus 169 MRSA with a Minimum Inhibitory Concentration (MIC) of 0.0625%.
- 04 Eucalyptus globulus essential oil also demonstrated excellent antioxidant activity, with an EC50 of 4.48 µL/mL.
Transparency
Dusting Analysis
The Formula
Formulation
Safety
Safety Profile
The CIR Expert Panel concluded that Eucalyptus globulus-derived ingredients (which are considered inclusive of Eucalyptus globulus and other species of Eucalyptus for Eucalyptus Globulus Leaf Oil) are safe in cosmetics. However, this is contingent on formulation to be non-sensitizing and adherence to specific concentration limits. For leave-on dermal applications, the highest safe concentration is 0.4%. Proper dilution and individual skin testing are highly recommended due to the potential for irritation and sensitization in some individuals. It should not be applied to the face, especially the nose, of infants or young children. No specific SCCS or FDA status was found for EUCALYPTUS LOXOPHLEBA LEAF OIL.
Your Skin
Skin Compatibility
Our Assessment
Verdict
EUCALYPTUS LOXOPHLEBA LEAF OIL is a valuable ingredient for precision skincare, offering robust antimicrobial, anti-inflammatory, and sebum-regulating benefits, but requires careful formulation within a 0.4% maximum for leave-on products to ensure safety and minimize irritation.
Related
Similar Ingredients
Finding similar ingredients…